JP2005512979A5 - - Google Patents

Download PDF

Info

Publication number
JP2005512979A5
JP2005512979A5 JP2003538188A JP2003538188A JP2005512979A5 JP 2005512979 A5 JP2005512979 A5 JP 2005512979A5 JP 2003538188 A JP2003538188 A JP 2003538188A JP 2003538188 A JP2003538188 A JP 2003538188A JP 2005512979 A5 JP2005512979 A5 JP 2005512979A5
Authority
JP
Japan
Prior art keywords
kdi
tripeptide
pharmaceutical composition
spinal cord
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003538188A
Other languages
English (en)
Japanese (ja)
Other versions
JP4312054B2 (ja
JP2005512979A (ja
Filing date
Publication date
Priority claimed from FI20012082A external-priority patent/FI20012082A0/fi
Application filed filed Critical
Publication of JP2005512979A publication Critical patent/JP2005512979A/ja
Publication of JP2005512979A5 publication Critical patent/JP2005512979A5/ja
Application granted granted Critical
Publication of JP4312054B2 publication Critical patent/JP4312054B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003538188A 2001-10-26 2002-10-25 生物学的活性ペプチドおよびそれを用いた損傷神経の修復 Expired - Fee Related JP4312054B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20012082A FI20012082A0 (fi) 2001-10-26 2001-10-26 Biologisesti aktiiviset peptidit hermovauroiden korjaamiseksi
PCT/FI2002/000831 WO2003035675A1 (en) 2001-10-26 2002-10-25 Biologically active peptides and their use for repairing injured nerves

Publications (3)

Publication Number Publication Date
JP2005512979A JP2005512979A (ja) 2005-05-12
JP2005512979A5 true JP2005512979A5 (https=) 2006-01-05
JP4312054B2 JP4312054B2 (ja) 2009-08-12

Family

ID=8562134

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003538188A Expired - Fee Related JP4312054B2 (ja) 2001-10-26 2002-10-25 生物学的活性ペプチドおよびそれを用いた損傷神経の修復

Country Status (10)

Country Link
US (3) US20040266991A1 (https=)
EP (1) EP1438329B1 (https=)
JP (1) JP4312054B2 (https=)
AT (1) ATE490972T1 (https=)
AU (1) AU2002336124B2 (https=)
CA (1) CA2465245C (https=)
DE (1) DE60238551D1 (https=)
DK (1) DK1438329T3 (https=)
FI (1) FI20012082A0 (https=)
WO (1) WO2003035675A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005029468A1 (de) * 2005-06-24 2006-12-28 Plt Patent & Licence Trading Ltd. Verwendung von Inhibitoren der N-Methyltransferasen in der Therapie des Parkinson-Syndroms
RU2301678C1 (ru) 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
CN101784869A (zh) * 2007-05-31 2010-07-21 赫兹公司 为归还租赁车辆的旅客自动生成航班登机牌的系统和方法
US8008253B2 (en) * 2007-07-03 2011-08-30 Andrew Tasker Treatment for anxiety
US20090247466A1 (en) * 2008-03-10 2009-10-01 University Of Louisville Research Foundation Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
GB201700529D0 (en) 2017-01-12 2017-03-01 Rogers April Laminin receptor peptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT276041B (de) * 1968-08-16 1969-11-10 Dragoco Gerberding Co Gmbh Verfahren zur Herstellung eines konzentrierten, praktisch sterilen Rohzwiebelaromas
US3590722A (en) * 1969-06-09 1971-07-06 Samuel Leptrone Flavor injector device
HU185263B (en) 1981-06-12 1984-12-28 Richter Gedeon Vegyeszet Process for producing peptides effective on the immuncontroll analogous with the tp5
FI922517L (fi) * 1992-05-29 1993-11-30 Paeivi Liesi Nervrepareringsmedel och dess anvaendning
GB9217316D0 (en) 1992-08-14 1992-09-30 Ludwig Inst Cancer Res Schwann cell mitogenic factor,its preparation and use
GB9324473D0 (en) 1993-11-29 1994-01-12 Oxford Res Support Co Ltd Isolation of streptokinase by affinity chromatography
AU710838B2 (en) * 1995-07-26 1999-09-30 Firmenich S.A. Flavoured products and a process for their preparation
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
DE19882746T1 (de) 1997-04-03 2001-10-18 California Inst Of Techn Enzymvermittelte Modifikation von Fibrin für das Gewebs-Engineering
US20020168718A1 (en) * 1997-04-03 2002-11-14 California Institute Of Technology Enzyme-mediated modification of fibrin for tissue engineering
US6075119A (en) * 1997-04-07 2000-06-13 The Rockefeller University Peptides useful for reducing symptoms of toxic shock syndrome
IL121191A0 (en) * 1997-06-29 1997-11-20 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
MXPA01010692A (es) 1999-04-22 2004-09-06 Univ Zuerich Matrices de proteina modificadas para ingenieria de tejidos o liberacion controlada.
DE20010297U1 (de) 2000-06-08 2000-08-31 ETH Zürich, Zürich Enzymvermittelte Modifizierung von Fibrin zur Gewebemanipulation: Fibrin-Formulierungen mit Peptiden

Similar Documents

Publication Publication Date Title
WO2001060381B1 (en) Nucleoside analogs with carboxamidine-modified bicyclic base
AP1818A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
EP0709376A3 (en) Therapeutic compounds
CY1107051T1 (el) Αντι-διηθητικα και αντι-αγγειογενετικα θραυσματα ουροκινασης και η χρηση τους
EP0528312A3 (en) Cyclic peptides and use thereof
ATE165100T1 (de) Peptide mit endothelin antagonistischer aktivität, deren herstellung und pharmazeutische zusammensetzungen
WO2004056314A3 (en) Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
EP1626055A3 (en) Non-mammalian GnRH analogs and uses thereof in the regulation of the immune system
WO2005056524A3 (en) Therapeutic agents useful for treating pain
WO2003048164A3 (en) Adenosine a2a receptor antagonists
NO963464L (no) Nye opioidpeptider for behandling av smerte og anvendelse derav
JP2008521840A5 (https=)
CN101316859A (zh) 用于治疗和预防病毒感染的环孢菌素a的芳基烷基和杂芳基烷基衍生物
JP2006506942A5 (https=)
WO1999033450A3 (en) Pharmaceutical composition containing sibutramine and orlistat
JP2002523437A5 (https=)
JP2005512979A5 (https=)
WO2003084979A3 (fr) Peptides et leur application en therapeutique
TW200633694A (en) Composition and method for treating asthma
Yang et al. Macrocyclic renin inhibitors: synthesis of a subnanomolar, orally active cysteine derived inhibitor
ATE513845T1 (de) Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
CA2465667A1 (en) New peptides - analogs of human growth hormone-releasing hormone
BG106180A (en) Pharmaceutical composition containing sibutramine and orlistat
CA2465245A1 (en) Biologically active peptides and their use for repairing injured nerves
RU2004128444A (ru) Способы и композиции для лечения желудочно-кишечной токсичности, вызванной цитодеструктивной терапией